Episodes

March 29, 2022

Accelerating Pediatric Drug Development: Regulatory and Industry Perspectives

In this episode, we are joined by Patrick Smith, PharmD, President, Integrated Drug Development, Certara and Lynne Yao, MD, Director, Division of Pediatric and Maternal Health, US FDA. They give us an overview of the pediatric drug development landscape, model-informed drug development, share best practices, and more. This episode is sponsored by Certara.
March 21, 2022

Dennis Lund, Associate Dean of the Faculty & CMO at Stanford University/Lucile Packard Children's Hospital

This episode features Dennis Lund, Associate Dean of the Faculty & CMO at Stanford University/Lucile Packard Children's Hospital. Here, he discusses stopping and starting surgeries throughout the pandemic, advice for navigating uncertainties, the lasting impact of COVID-19, and more.
March 21, 2022

Dennis Lund, Associate Dean of the Faculty & CMO at Stanford University/Lucile Packard Children's Hospital

This episode features Dennis Lund, Associate Dean of the Faculty & CMO at Stanford University/Lucile Packard Children's Hospital. Here, he discusses stopping and starting surgeries throughout the pandemic, advice for navigating uncertainties, the lasting impact of COVID-19, and more.
March 21, 2022

Dennis Lund, Associate Dean of the Faculty & CMO at Stanford University/Lucile Packard Children's Hospital

This episode features Dennis Lund, Associate Dean of the Faculty & CMO at Stanford University/Lucile Packard Children's Hospital. Here, he discusses stopping and starting surgeries throughout the pandemic, advice for navigating uncertainties, the lasting impact of COVID-19, and more.
March 18, 2022

Barbara Joers, President and CEO at Gillette Children's Specialty Healthcare

This episode features Barbara Joers, President and CEO at Gillette Children's Specialty Healthcare. Here, she discusses the challenge of preventative health care efforts for children with the decline of immunizations due to lack of access during the pandemic, dealing with the workforce shortage, equity and inclusivity of pediatrics, and more.
March 18, 2022

Barbara Joers, President and CEO at Gillette Children's Specialty Healthcare

This episode features Barbara Joers, President and CEO at Gillette Children's Specialty Healthcare. Here, she discusses the challenge of preventative health care efforts for children with the decline of immunizations due to lack of access during the pandemic, dealing with the workforce shortage, equity and inclusivity of pediatrics, and more.
March 18, 2022

Barbara Joers, President and CEO at Gillette Children's Specialty Healthcare

This episode features Barbara Joers, President and CEO at Gillette Children's Specialty Healthcare. Here, she discusses the challenge of preventative health care efforts for children with the decline of immunizations due to lack of access during the pandemic, dealing with the workforce shortage, equity and inclusivity of pediatrics, and more.
March 14, 2022

Dr. Kristina Deeter, M.D., MBA, on COVIDs Disruption to Pediatric Care

In this episode, we are joined by Dr. Kristina Deeter, M.D., MBA, Specialty Medical Officer for Pediatric Critical Care Medicine with Pediatrix Medical Group and Vice Chair of Pediatrics at Renowned Children's Hospital in Reno, Nevada to discuss the pandemic's effect on pediatric care. She examines the long-term mental health effects in children and young adults, the benefits to regionalization of care and the importance of smaller PICUs remaining in communities, and actionable insights to carin...
March 14, 2022

Dr. Kristina Deeter, M.D., MBA, on COVIDs Disruption to Pediatric Care

In this episode, we are joined by Dr. Kristina Deeter, M.D., MBA, Specialty Medical Officer for Pediatric Critical Care Medicine with Pediatrix Medical Group and Vice Chair of Pediatrics at Renowned Children's Hospital in Reno, Nevada to discuss the pandemic's effect on pediatric care. She examines the long-term mental health effects in children and young adults, the benefits to regionalization of care and the importance of smaller PICUs remaining in communities, and actionable insights to carin...
March 14, 2022

Dr. Kristina Deeter, M.D., MBA, on COVIDs Disruption to Pediatric Care

In this episode, we are joined by Dr. Kristina Deeter, M.D., MBA, Specialty Medical Officer for Pediatric Critical Care Medicine with Pediatrix Medical Group and Vice Chair of Pediatrics at Renowned Children's Hospital in Reno, Nevada to discuss the pandemic's effect on pediatric care. She examines the long-term mental health effects in children and young adults, the benefits to regionalization of care and the importance of smaller PICUs remaining in communities, and actionable insights to carin...
March 1, 2022

Matthew Love, President and CEO at Nicklaus Children's Health System

This episode features Matthew Love, President and CEO at Nicklaus Children's Health System. Here, he discusses the importance of focusing on the fundamentals of providing amazing care, operational excellence, building the future, and concentrating on the healthsystem as a whole.
March 1, 2022

Matthew Love, President and CEO at Nicklaus Children's Health System

This episode features Matthew Love, President and CEO at Nicklaus Children's Health System. Here, he discusses the importance of focusing on the fundamentals of providing amazing care, operational excellence, building the future, and concentrating on the healthsystem as a whole.
March 1, 2022

Matthew Love, President and CEO at Nicklaus Children's Health System

This episode features Matthew Love, President and CEO at Nicklaus Children's Health System. Here, he discusses the importance of focusing on the fundamentals of providing amazing care, operational excellence, building the future, and concentrating on the healthsystem as a whole.
Dec. 15, 2021

Emerging Trends and Challenges with Pediatric Drug Development

In this episode, Max Williamson, a Patient Representative for the UK National Cancer Research Institute, and Karen Rowland Yeo, PhD, Senior Vice President at Certara, discuss the challenges in pediatric drug development, including accessibility issues for young people and the need for more qualitative data. Max and Karen also talk about how technology can accelerate getting new medicines to children as well as emerging trends in the space over the next 5 years. This podcast is sponsored by Cert...
Dec. 15, 2021

Emerging Trends and Challenges with Pediatric Drug Development

In this episode, Max Williamson, a Patient Representative for the UK National Cancer Research Institute, and Karen Rowland Yeo, PhD, Senior Vice President at Certara, discuss the challenges in pediatric drug development, including accessibility issues for young people and the need for more qualitative data. Max and Karen also talk about how technology can accelerate getting new medicines to children as well as emerging trends in the space over the next 5 years. This podcast is sponsored by Cert...
Dec. 15, 2021

Emerging Trends and Challenges with Pediatric Drug Development

In this episode, Max Williamson, a Patient Representative for the UK National Cancer Research Institute, and Karen Rowland Yeo, PhD, Senior Vice President at Certara, discuss the challenges in pediatric drug development, including accessibility issues for young people and the need for more qualitative data. Max and Karen also talk about how technology can accelerate getting new medicines to children as well as emerging trends in the space over the next 5 years. This podcast is sponsored by Cert...
Nov. 17, 2021

R. Lawrence Moss, President and CEO at Nemours Children’s Health System

This episode features R. Lawrence Moss, M.D., President and CEO at Nemours Children’s Health System. Here, he discusses how his strategies are evolving, what his top priorities are, and more
Nov. 17, 2021

R. Lawrence Moss, President and CEO at Nemours Children’s Health System

This episode features R. Lawrence Moss, M.D., President and CEO at Nemours Children’s Health System. Here, he discusses how his strategies are evolving, what his top priorities are, and more
Nov. 17, 2021

R. Lawrence Moss, President and CEO at Nemours Children’s Health System

This episode features R. Lawrence Moss, M.D., President and CEO at Nemours Children’s Health System. Here, he discusses how his strategies are evolving, what his top priorities are, and more
Nov. 8, 2021

John Brownstein, Chief Innovation Officer at Boston Children’s Hospital

This episode features John Brownstein, Chief Innovation Officer at Boston Children’s Hospital. Here, he discusses his role as Chief Innovation Officer, his pride in Boston Children's Hospital, and more
Nov. 8, 2021

John Brownstein, Chief Innovation Officer at Boston Children’s Hospital

This episode features John Brownstein, Chief Innovation Officer at Boston Children’s Hospital. Here, he discusses his role as Chief Innovation Officer, his pride in Boston Children's Hospital, and more
Nov. 8, 2021

John Brownstein, Chief Innovation Officer at Boston Children’s Hospital

This episode features John Brownstein, Chief Innovation Officer at Boston Children’s Hospital. Here, he discusses his role as Chief Innovation Officer, his pride in Boston Children's Hospital, and more
Nov. 3, 2021

Robert Steele, Chief Strategy Officer and Innovation Officer at Children’s Mercy Kansas City

This episode features Robert Steele, Chief Strategy Officer and Innovation Officer at Children’s Mercy Kansas City. Here, he discusses his career journey, pride in his system, and more.
Nov. 3, 2021

Robert Steele, Chief Strategy Officer and Innovation Officer at Children’s Mercy Kansas City

This episode features Robert Steele, Chief Strategy Officer and Innovation Officer at Children’s Mercy Kansas City. Here, he discusses his career journey, pride in his system, and more.